Find Your Funding Opportunity
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
05-20-2024 | $1.1 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 1
- Opportunity Type Discretionary
-
CFDA
93.103 -- Food and Drug Administration Research
Description
The purpose of this Funding Opportunity Announcement (FOA) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
Foreign OrganizationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
Key Date(s)
- March 14, 2024: Last Updated Date
- March 14, 2024: Posted Date
- May 20, 2024: Current Closing Date for Applications
- May 20, 2024: Application Due Date
- June 19, 2024: Application Archive Date
Contact Information
Zahara Graves
Grantor